International Patent: SYNERGISTIC CONJUGATED DRUGS WITH DUAL-PAYLOAD FOR TUMOR IMMUNOLOGY AND USE THEREOF

GENEVA, Sept. 24 -- SHANGHAI AFFINITY BIOPHARMACEUTICAL CO. LTD. filed a patent application (CN2026/084409) for “SYNERGISTIC CONJUGATED DRUGS WITH DUAL-PAYLOAD FOR TUMOR IMMUNOLOGY AND USE THEREOF”. With publication no. WO/2026/194965, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 47/68

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....